Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial D-1224-2014

Black Ant, 4600 mg x 4. Product is packaged in a small green box with gold lettering on the front, the back side of the box contains mostly foreign character. Within the box there are four (4) capsules individually wrapped in black and red plastic with white lettering. UPC 4026666142546 (product numbers may possibly vary for same product identification and same product packaging).

Publicado el 16 de abril de 2014 · Inicio del retiro: 30 de abril de 2013

Resumen

FDA registra el retiro D-1224-2014 de medicamentos de Clase I, publicado el 16 de abril de 2014 e iniciado el 30 de abril de 2013. Empresa responsable: American Lifestyle.Com; Estado: Finalizado; Cantidad reportada: 3 boxes distributed domestically & 4 boxes distributed internationally to consumers.; Lote: All lots, UPC 4026666142546. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil. Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs.

Qué hacer

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
American Lifestyle.Com
Distribuidor
Domestic distribution currently under Investigation; International distribution includes, but may not be limited to the following countries : Mexico, France, Brazil, Belgium, Denmark, Switzerland, Spain, Canada, Italy, Japan, Ireland, Venezuela, Oman.
UPC
4026666142546
Lote
All lots, UPC 4026666142546.
Clasificación de riesgo
Class I
Área (FDA)
drug
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Black Ant, 4600 mg x 4. Product is packaged in a small green box with gold lettering on the front, the back side of the box contains mostly foreign character. Within the box there are four (4) capsules individually wrapped in black and red plastic with white lettering. UPC 4026666142546 (product numbers may possibly vary for same product identification and same product packaging). fue retirado del mercado?

Sí. FDA publicó el retiro D-1224-2014 el 16 de abril de 2014. Peligro reportado: Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil. Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

¿Cómo sé si mi unidad está incluida en el retiro?

Compara los datos de tu producto con los del aviso. UPC: 4026666142546.